drugset / Trial / NCT03415659
Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, dose-escalation/dose-expansion, phase I clinical trial study to investigate the safety, tolerability, and efficacy of HWH340. In addition, the pharmacokinetic characteristics will also be investigated. Three parts are included in this study.
Timeline
- Start
- 2018-03-05
- Primary completion
- 2021-03-30
- Completion
- 2021-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HWH340 | Unknown | 20 mg | Oral |
| Subject | HWH340 | Unknown | 520 mg | Oral |